Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

bIosimilar of aDalimumab, an European evAluation

Fresenius Kabi · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
psoriatic-arthritisrheumatoid-arthritisulcerative-colitis
The study objective is aimed to describe all country, site, investigator and patient variables that lead to treatment persistence for at least 12 months among patients with rheumatologic and intestinal chronic inflammatory diseases who were switched to FK adalimumab, in order to develop a model to predict persistence at 12 months.
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1138583
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive